Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Brest
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients eligible for prostate brachytherapy
Male patients, aged at least 18 years with no age limit.
Prostate adenocarcinoma with proved histology (prostate biopsy)
Localized disease: Negative extension (TAP + TAP + bone scintigraphy)
Absence of contraindications to surgery or general anesthesia Prostatic volume less than or equal to 60 cc
Prognostic group of "low risk" according to the classification of D'Amico (Gleason less than or equal to 6 AND PSA \<10ng / ml AND less than or equal to T2a to the rectal touch)
Prognostic group "favorable intermediate" according to the classification of D'Amico (with no more than one criterion among the following: Gleason 7 (3 + 4), PSA \<15ng / ml, less than half of the positive biopsies). Note: Gleason 7 (4 + 3) are excluded.
Absence of prophylactic capsular collapse on prostatic MRI
Absence of irritative urinary signs too important
No history of pelvic irradiation
Absence of colorectal inflammatory disease in evolutionary thrust
Informed Consent
Affiliated to a social security scheme or beneficiary
You may not be if
A protected major person within the meaning of the Public Health Code
Refus or inability to give informed consent
NO-indication to CT SCAN and MRI
Clareo Health | Innovative Planning and Guidance System for Prostate Focal Brachytherapy
